Clinical Trial Update: A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA) [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for LY4298445, recruiting in healthy participants and in individuals with systemic lupus erythematosus or rheumatoid art…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis
• Systemic Lupus Erythematosus

Drugs mentioned

• LY4298445

Snippet

Sponsor: Eli Lilly and Company | Conditions: Healthy, Systemic Lupus Erythematosus | Phase 1 | Status: RECRUITING